Antibiotic prescribing practices in the presence of extended-spectrum β-lactamase (ESBL) positive organisms in an adult intensive care unit in South Africa – A pilot studyFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 4 December 2018

References

• O'Neill J. Securing new drugs for future generations: the pipeline of antibiotics. The review of antimicrobial resistance. Available at URL: http://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf.
   Google Scholar
• Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ 2016;94(8):558-a; WHO. Global action plan on antimicrobial resistance. Available at URL: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/.
   Google Scholar
• N.SchellackD.BenjaminA.BrinkA situational analysis of current antimicrobial governance, regulation, and utilization in South AfricaInt J Infect Dis642017100106
   PubMed Web of Science ®Google Scholar
• J.C.MeyerN.SchellackJ.StokesOngoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary studyFront Pharmacol82017751
   PubMed Web of Science ®Google Scholar
• S.NakwatumbahD.KibuuleB.GodmanCompliance to guidelines for the prescribing of antibiotics in acute infections at Namibia's national referral hospital: a pilot study and the implicationsExpert Rev Anti-infect Ther1572017713721
   PubMed Web of Science ®Google Scholar
• T.B.MatsitseE.HelbergJ.C.MeyerB.GodmanA.MasseleN.SchellackCompliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implicationsExpert Rev Anti-infect Ther15102017963972
   PubMed Web of Science ®Google Scholar
• Schellack N, Dlamini N, Meyer JC, Godman B. Point prevalence survey of antimicrobial utilisation in an academic hospital in the Gauteng province, South Africa. MURIA 3 2017; Available at URL: http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf.
   Google Scholar
• N.van der SandtN.SchellackL.A.MabopeM.P.MawelaD.KrugerB.GodmanSurgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settingsPediatr Infect Dis J2018
   Web of Science ®Google Scholar
• A.BrinkJ.CoetzeeC.ClayThe spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and preventionS Afr Med J1022012599601
   Web of Science ®Google Scholar
• A.HuttnerS.HarbarthJ.CarletAntimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum Available at URL:Antimicrob Resist Infect Control2201331
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Delivering safe care for patients: all healthcare providers play a role. Get Smart About Antibiot. Available at: http://www.cdc.gov/getsmart/healthcare/pdfs/GetSmartWeek_Providers. [accessed 8 October 2015].
   Google Scholar
• Rishi H, Dhillon P, Clark J. ESBLs: a clear and present danger? Crit Care Res Pract. Article ID 625170, 11 pages. Available at: http://dx.doi.org/10.1155/2012/625170.
   Google Scholar
• J.CoetzeeA.BrinkThe emergence of carbapenem resistance in Enterobacteriaceae in South AfricaS Afr J Epidemiol Infect2642011 Part II
   Google Scholar
• C.BamfordK.BonorchisA.RyanAntimicrobial susceptibility patterns of Escherichia coli strains isolated from urine samples in South Africa from 2007–2011S Afr J Epidemiol Infect272201246
   Google Scholar
• K.E.GregoryL.RadovinskyResearch strategies that result in optimal data collection from the patient medical recordAppl Nurs Res2522012108116
   PubMed Web of Science ®Google Scholar
• C.OkothS.OpangaF.OkaleboM.OlukaA.Baker KurdiB.GodmanPoint prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implicationsHosp Pract1–92018
   Google Scholar
• A.VersportenG.BolokhovetsL.GhazaryanAntibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for EuropeLancet Infect Dis1452014381387
   PubMed Web of Science ®Google Scholar
• WHO. WHO collaborating centre for drug statistics methodology. ATC/DDD Index. Available at URL: http://www.whocc.no/.
   Google Scholar
• Centers for Disease Control and Prevention. Healthcare associated infections; 2014. Available at: http://www.cdc.gov.
   Google Scholar
• E.LautenbachJ.B.PatelW.B.BilkerExtended-spectrum β-lactamase–producing escherichia coli and klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesClin Infect Dis32200111621171
   PubMed Web of Science ®Google Scholar
• M.E.CharlsonP.PompeiK.L.AlesA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chron Dis4051987373383
   PubMedGoogle Scholar
• M.E.CharlsonR.E.CharlsonJ.C.PetersonThe Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patientsJ Clin Epidemiol61200812341240
   PubMed Web of Science ®Google Scholar
• M.CharlsonT.P.SzatrowskiJ.PetersonValidation of a combined comorbidity indexJ Clin Epidemiol47199412451251
   PubMed Web of Science ®Google Scholar
• J.C.PetersonS.A.PagetM.S.LachsThe risk of comorbidityAnn Rheum Dis7152012635637
   Web of Science ®Google Scholar
• C.C.YangP.ChenC.HsuValidity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort studyAppl Nurs Res2522012108116
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 2016. Available at: http://www.clsi.org/standards/products/microbiology/documents/m100/.
   Google Scholar
• B.CrowleyG.RatcliffeExtended-spectrum β-lactamases in Enterobacter cloacae: underestimated but clinically significant!J Antimicrob Chemother51200313161317
   Web of Science ®Google Scholar
• Dey D, Biswas K, Banerjee A, Banerjee P, Ray R, Das S. Distribution of ESBL producer organisms based on patients’ age and gender; 2010. Available at URL: http://www.academia.edu/11436038/Distribution_of_ESBL_producer_organisms_based_on_patients_age_and_gender.
   Google Scholar
• J.ThamExtended-spectrum β-lactamase-producing enterobacteriaceae: epidemiology, risk factors, and duration of carriage Available at:2012Department of Clinical Sciences, Malmö Infectious Disease Research Unit, Lund University
   Google Scholar
• A.A.KramerJ.E.ZimmermanA predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stayBMC Med Inf Decis Mak10201027
   Web of Science ®Google Scholar
• S.ShaikhJ.FatimaB.ShakilRisk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitalsSaudi J Biol Sci22120153741
   PubMed Web of Science ®Google Scholar
• E.I.KritsotakisC.TsioutisM.RoumbelakiAntibiotic use and the risk of carbapenem-resistant extended-spectrum-betaβ-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case–control studyJ Antimicrob Chemother666201113831391
   PubMed Web of Science ®Google Scholar
• A.ManhasP.AggarwalM.BalaESBL detection prevalence and comparison with new criteriaJ Evol Med Dent Sci132012209
   Google Scholar
• Pannell DJ. Sensitivity analysis: strategies, methods, concepts, examples; 2017 Available at: http://dpannell.fnas.uwa.edu.au/dpap971f.htm.
   Google Scholar
• F.V.Van DaalenM.C.KallenM.C.A.Van den BoschClinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infectionsEur J Clin Microbiol Infect Dis.3610201718531858
   Web of Science ®Google Scholar
• J.A.CoxE.VliegheM.MendelsonAntibiotic stewardship in low- and middle-income countries: the same but different?Clin Microbiol Infect23112017812818
   PubMed Web of Science ®Google Scholar
• D.A.GoffM.MendelsonAntibiotic stewardship hits a home run for patientsThe Lancet Infect Dis1792017892893
   Web of Science ®Google Scholar
• Z.NasrB.ParavattilK.J.WilbyThe impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic reviewEastern Mediterr Health J2362017430440
   PubMed Web of Science ®Google Scholar
• B.WagnerG.A.FiliceD.DrekonjaAntimicrobial stewardship programs in inpatient hospital settings: a systematic reviewInfect Control Hosp Epidemiol3510201412091228
   Web of Science ®Google Scholar
• B.KimJ.KimB.KimJ.KimS.W.KimH.PaiA survey of antimicrobial stewardship programs in Korea, 2015J Korean Med Sci3110201615531559
   Web of Science ®Google Scholar
• N.SchellackE.BronkhorstR.CoetzeeSASOCP Position statement on the pharmacist’s role in antibiotic stewardship 2018South Afr J Infect Dis33120182835
   Google Scholar
• L.A.PollackD.PlachourasR.Sinkowitz-CochranH.GruhlerD.L.MonnetJ.T.WeberA concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panelInfect Control Hosp Epidemiol3710201612011211
   PubMed Web of Science ®Google Scholar